STAAR Surgical to Ring Nasdaq Stock Market Closing Bell Following Vision 2026 Investor Day on September 14, 2023
14 Setembro 2023 - 8:00AM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of implantable lenses for the eye, will
host Vision 2026, the Company’s investor day, at the Nasdaq
MarketSite in Times Square today. To honor the occasion and
celebrate the 40th anniversary of being listed as a public company,
Tom Frinzi, Chair of the Board and CEO, along with the company’s
executive leadership team and STAAR employees, have been invited to
ring the Nasdaq closing bell on Thursday, September 14.
The Vision 2026 Investor Day will highlight key company
initiatives and projects, as well as the significant global growth
opportunities ahead for STAAR and its game-changing EVO ICL family
of lenses for vision correction. Several leading refractive
surgeons from around the world will speak to their experience with
EVO ICL and share feedback from delighted EVO patients who no
longer have to deal with the hassles of glasses and contact lenses
and the reasons they chose EVO ICL.
Click here for a live stream of the Vision 2026 Investor Day,
which will begin at approximately 8:30 a.m. ET.
A live stream of the Nasdaq Closing Bell will be available at:
https://www.nasdaq.com/marketsite/bell-ringing-ceremony
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 40 years, designs, develops, manufactures and markets
implantable lenses for the eye. These lenses are intended to
provide visual freedom for patients, lessening or eliminating the
reliance on glasses or contact lenses. All of these lenses are
foldable, which permits the surgeon to insert them through a small
incision. STAAR’s lens used in refractive surgery is called an
Implantable Collamer® Lens or “ICL”, which includes the EVO ICL™
product line. More than 2,000,000 ICLs have been sold to date and
STAAR markets these lenses in over 75 countries. To learn more
about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA,
the company operates manufacturing and packaging facilities in
Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more
information, please visit the Company’s website at
www.staar.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230914614729/en/
Investors & Media Brian Moore Vice President,
Investor, Media Relations and Corporate Development (626) 303-7902,
Ext. 3023 bmoore@staar.com
STAAR Surgical (NASDAQ:STAA)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
STAAR Surgical (NASDAQ:STAA)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024